STAG3L5P

Across TCGA pan-cancer cohorts, STAG3L5P Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated STAG3L5P data layer compared with 24 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher STAG3L5P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated STAG3L5P expression acts as an unfavorable survival marker.

COAD and ACC are the cancer types where STAG3L5P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.125	0.801	<.001	33	view →
ACC	DFS	Median	All	0.195	0.748	.003	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

STAG3L5P–COAD (OS)

Open the COAD breakdown →